Brandywine Global Investment Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Brandywine Global Investment Management, LLC

$14.2 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$28.51 - $32.9 $6.45 Million - $7.45 Million	-226,345 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$23.54 - $31.39 $425,791 - $567,782	-18,088 Reduced 7.4%	226,345 $6.04 Million
Q2 2021 Aug 13, 2021	SELL	$26.72 - $33.19 $228,616 - $283,973	-8,556 Reduced 3.38%	244,433 $7.53 Million
Q1 2021 May 13, 2021	SELL	$24.15 - $31.45 $303,372 - $395,074	-12,562 Reduced 4.73%	252,989 $6.62 Million
Q4 2020 Feb 10, 2021	BUY	$17.7 - $25.81 $724,779 - $1.06 Million	40,948 Added 18.23%	265,551 $6.68 Million
Q3 2020 Nov 12, 2020	BUY	$20.2 - $25.05 $4.54 Million - $5.63 Million	224,603 New	224,603 $4.68 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

Black Rock Inc. New York, NY

10.4M
Shares

$379 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.13M
Shares

$224 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.1M
Shares

$186 Million
2.64% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.88M
Shares

$105 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

2.63M
Shares

$96 Million
0.09% of portfolio

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.95B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account